129Xenon MRI MERCK Study (IIS)
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Merck Sharp & Dohme LLC.
Start Date
May 15, 2024
End Date
February 4, 2029
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Merck Sharp & Dohme LLC.
Start Date
May 15, 2024
End Date
February 4, 2029